Literature DB >> 24552182

Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.

Xiangyu Zheng1, Yifang Wang, Ben Liu, Chunqing Liu, Dandan Liu, Jie Zhu, Chunhui Yang, Jiangzhou Yan, Xiaobo Liao, Xiuxiang Meng, Hong Yang.   

Abstract

B lymphoma Mo-MLV insertion region 1 (Bmi-1) is highly expressed in a variety of cancers and has been shown to regulate cell proliferation. The INK4a/ARF tumor suppressor gene locus is one of the major targets of Bmi-1. In the present study, we chose two lung adenocarcinoma cell lines, A549 cells (without INK4a locus) and SPC-A1 cells (with INK4a locus), to investigate if the small hairpin RNA-mediated knockdown of Bmi-1 could inhibit the proliferation of lung adenocarcinoma cells, and to delineate the possible mechanism underlying Bmi-1 modulation of cell proliferation. We also investigated the potential pathway underlying Bmi-1 regulation of lung adenocarcinoma cell proliferation in different genetic backgrounds. To this end, we used shRNA to knockdown Bmi-1 expression in lung adenocarcinoma cells, which led to inhibition of cell growth, colony formation in vitro, and tumorigenesis in vivo. In addition, phosphorylated Akt and cyclin D1 expression were downregulated, p21 and p27 levels were upregulated, and p16 expression remained unchanged in SPC-A1 cells. These data indicate that Bmi-1 might modulate the growth of lung adenocarcinoma cells in an INK4a-p16 independent pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24552182      PMCID: PMC4026377          DOI: 10.1089/nat.2013.0459

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  28 in total

1.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 2.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

3.  Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.

Authors:  M van Lohuizen; S Verbeek; B Scheijen; E Wientjens; H van der Gulden; A Berns
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

4.  Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.

Authors:  Li-Bing Song; Mu-Sheng Zeng; Wen-Ting Liao; Ling Zhang; Hao-Yuan Mo; Wan-Li Liu; Jian-Yong Shao; Qiu-Liang Wu; Man-Zhi Li; Yun-Fei Xia; Li-Wu Fu; Wen-Lin Huang; Goberdhan P Dimri; Vimla Band; Yi-Xin Zeng
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.

Authors:  Hongjuan Cui; Jun Ma; Jane Ding; Tai Li; Goleeta Alam; Han-Fei Ding
Journal:  J Biol Chem       Date:  2006-09-18       Impact factor: 5.157

6.  Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.

Authors:  Shinichi Toyooka; Masaki Tokumo; Hisayuki Shigematsu; Keitaro Matsuo; Hiroaki Asano; Kunitoshi Tomii; Shuji Ichihara; Makoto Suzuki; Motoi Aoe; Hiroshi Date; Adi F Gazdar; Nobuyoshi Shimizu
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

Review 7.  Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.

Authors:  Etsu Tashiro; Ayako Tsuchiya; Masaya Imoto
Journal:  Cancer Sci       Date:  2007-03-14       Impact factor: 6.716

8.  Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.

Authors:  R H J Breuer; P J F Snijders; G T Sutedja; R G A B Sewalt; A P Otte; P E Postmus; C J L M Meijer; F M Raaphorst; E F Smit
Journal:  Lung Cancer       Date:  2005-06       Impact factor: 5.705

9.  BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

Authors:  Masashi Sawa; Kazuhito Yamamoto; Toshiya Yokozawa; Hitoshi Kiyoi; Asahi Hishida; Tomohiro Kajiguchi; Masao Seto; Akio Kohno; Kunio Kitamura; Yoshie Itoh; Norio Asou; Nobuyuki Hamajima; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

10.  Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival.

Authors:  M K Kang; R H Kim; S J Kim; F K Yip; K-H Shin; G P Dimri; R Christensen; T Han; N-H Park
Journal:  Br J Cancer       Date:  2006-12-19       Impact factor: 7.640

View more
  8 in total

1.  Bmi-1 expression modulates non-small cell lung cancer progression.

Authors:  Dan Xiong; Yunlin Ye; Yujie Fu; Jinglong Wang; Bohua Kuang; Hongbo Wang; Xiumin Wang; Lidong Zu; Gang Xiao; Mingang Hao; Jianhua Wang
Journal:  Cancer Biol Ther       Date:  2015-04-16       Impact factor: 4.742

2.  mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.

Authors:  David R Driscoll; Saadia A Karim; Makoto Sano; David M Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I Jodrell; T R Jeffry Evans; Nabeel Bardeesy; Michael N Hall; Brian J Quattrochi; David S Klimstra; Simon T Barry; Owen J Sansom; Brian C Lewis; Jennifer P Morton
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

3.  p38 MAPK is Crucial for Wnt1- and LiCl-Induced Epithelial Mesenchymal Transition.

Authors:  Chun-Xiao Fang; Chun-Mei Ma; Ling Jiang; Xi-Ming Wang; Na Zhang; Ji-Na Ma; Tai-Hua Wu; Zhong-He Zhang; Guang-Dong Zhao; Ya-Dong Zhao
Journal:  Curr Med Sci       Date:  2018-06-22

4.  Delivery of Sonic Hedgehog Gene Repressed Irradiation-induced Cellular Senescence in Salivary Glands by Promoting DNA Repair and Reducing Oxidative Stress.

Authors:  Bo Hai; Qingguo Zhao; Michael A Deveau; Fei Liu
Journal:  Theranostics       Date:  2018-01-13       Impact factor: 11.556

5.  Morusin inhibits the growth of human colorectal cancer HCT116‑derived sphere‑forming cells via the inactivation of Akt pathway.

Authors:  Yuqi Zhou; Xiangyong Li; Min Ye
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

Review 6.  The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies.

Authors:  Jie Xu; Lin Li; Pengfei Shi; Hongjuan Cui; Liqun Yang
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

7.  Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.

Authors:  Arnold Bolomsky; Karin Schlangen; Wolfgang Schreiner; Niklas Zojer; Heinz Ludwig
Journal:  J Hematol Oncol       Date:  2016-03-02       Impact factor: 17.388

8.  Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway.

Authors:  Xiaojuan Li; Yunping Tang; Fangmiao Yu; Yu Sun; Fangfang Huang; Yan Chen; Zuisu Yang; Guofang Ding
Journal:  Mar Drugs       Date:  2018-09-11       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.